通过数字扫描与传统视觉方法比较使用inter-和intra-grader的可靠性,用于评估临床前II类复合制剂的II类复合制剂
Amr Ahmed Azhari1, Walaa Magdy Ahmed1, Raghad Almaghrabi2
1Department of Restorative Dentistry, Faculty of Dentistry, King Abdulaziz University, Jeddah, Saudi Arabia.
The Saudi dental journal
|September 17, 2024
概括
与传统的视觉分级方法 (VGM) 相比,数字分级方法 (DGM) 在评估II类复合制剂方面显示出更高的可靠性和一致性. 这一发现对于牙科教育和评估至关重要.
科学领域:
- 牙科材料科学 牙科材料科学
- 牙科教育技术 牙科教育技术
- 临床评估方法临床评估方法
背景情况:
- 对牙科准备的准确评估对于学生的培训至关重要.
- 传统的视觉分级方法 (VGM) 可能在一致性方面存在局限性.
- 数字口腔内扫描仪为客观评估提供了新的可能性.
研究的目的:
- 为了比较视觉分级方法 (VGM) 与II类复合制剂的数字分级方法 (DGM) 的分级器内和分级器间的可靠性.
- 评估三种不同的数字口腔内扫描仪在评估腔室制备中的性能.
- 确定数字方法是否比视觉评估提供了更好的一致性.
主要方法:
- 评估了使用II类复合制剂的95种类型牙.
- 使用传统的视觉分级方法 (VGM) 和使用相同标题的数字分级方法 (DGM) 进行了评估.
- 三台口腔内扫描仪 (i700,Trios 4,Shinning 3D) 用于数字扫描,由四名校准检查员进行评估.
主要成果:
- 在检查人员和评估技术之间发现了统计学上显著的相互作用 (P = 0.001).
- 准备牙的总分数在视觉分级方法 (VGM) 和数字分级方法 (DGM) 之间有所不同.
- 在使用VGM时,体内的一致性较低,但在使用DGM时有所改善.
结论:
- 检查员和评估方法都对II类复合制剂的评估产生重大影响.
- 与VGM相比,数字分级方法 (DGM) 在评估者内部和评估者间的评估中显示出潜在的更高可靠性和一致性.
- 这些发现表明,DGM可能是评估教育环境中牙科准备质量的优越方法.
相关概念视频
Imaging Studies II: Positron Emission Tomography and Scintigraphy
Positron Emission Tomography (PET) is a medical imaging technique that provides crucial insights into the body's physiological functions at a molecular level. It is an indispensable resource for diagnosing, staging, and monitoring various illnesses, notably cancer, neurological disorders, and cardiovascular conditions.
Fundamental Principles of PET
Fundamental Principles of PET
Equivalence: In Vitro and In Vivo Bioequivalence
Bioequivalence studies are crucial in evaluating whether new drugs can match an approved one regarding pharmacological effects and clinical performance. These studies test if drugs, despite different dosage forms, share identical plasma concentration-time profiles. Three types of equivalence are central to these studies: chemical, pharmaceutical, and therapeutic. Chemical equivalence indicates that two or more drug products contain identical active ingredients in equal amounts. Pharmaceutical...
Bioequivalence studies: Biowaivers
In certain scenarios, in vitro dissolution tests can replace in vivo bioequivalence studies. This is particularly true when a drug product, though available in varying strengths, maintains proportional similarity in its active and inactive ingredients. In such cases, the need for in vivo bioequivalence studies for lower strength variants may be waived, provided dissolution tests and in vivo studies on the highest strength yield satisfactory results.Bioequivalence can be indicated through...
Drug Product Performance: In Vitro–In Vivo Correlation
In pharmaceutical development, it's crucial to establish a predictive in vitro–in vivo correlation (IVIVC) for two or more formulations to gain a comprehensive understanding of release properties. IVIVC reduces the need for costly in vivo studies and facilitates the establishment of meaningful dissolution specifications with significant cost savings and decreased regulatory burden. Furthermore, a meaningful IVIVC should predict Cmax and AUC within 20%, aligning with FDA guidance while adhering...


